greeksoup/ stock research
Stock research / United States / CVS / Filings

CVS Health Corp. SEC filings

CVS Health filed 20 documents with the SEC in the last twelve months, the latest report being the 10-Q of 4 November 2026. The latest filing, on 4 November 2026, was an 8-K: regulation fd disclosure.

Filings in twelve months2010 of them 8-K news
Latest report10-Qfiled 4 Nov 2026
Latest filing8-K4 Nov 2026
Last results, two-day move-11.1%results filed 4 Nov 2026
New to this? How to read this page
  1. Companies file with the SEC when something happens. 10-Q and 10-K are the quarterly and annual reports; 8-K is news that cannot wait for the next report.
  2. An 8-K says which items it covers, such as results, a change at the top or a big contract. A foreign company files a 6-K instead.
  3. The results release is usually an 8-K filed the day results come out, before the 10-Q or 10-K.
  4. Every filing links to the original on EDGAR, the SEC's own site.

Twelve months of filings

by kind

Most of the filings were other company news (6). Results came out 4 times.

Each mark is one filing on the day it was filed, in rows by kind. Hover or tap a mark for the form and what it was about.

The share price around each results release

close before to close after

Over the last 4 releases the share price moved 7.2% on average in the two days around results, the most on 4 Nov 2026 (-11.1%).

10 Feb 2026+1.6%$75.77 to $77.02
6 May 2026+8.3%$80.69 to $87.36
5 Aug 2026-7.9%$104.42 to $96.22
4 Nov 2026-11.1%$91.47 to $81.33
Daily closeResults filed

Each ring marks a results filing. The move runs from the last close before the filing to the first close after it, so it covers results released before the open or after the close. Hover the line for any day's close.

What the company told investors on 8-K

10 filings

CVS Health's 10 news filings (8-K) were mostly about results of operations (4) and regulation FD disclosure (3).

  • Results of operationsThe quarterly results release
    4 · latest 4 Nov 2026
  • Regulation FD disclosureMaterial shared with investors, often slides or a presentation
    3 · latest 4 Nov 2026
  • Officer or director changeSomeone joined, left or changed role at the top
    3 · latest 17 Aug 2026
  • Shareholder voteResults of a vote at a shareholder meeting
    1 · latest 18 May 2026
  • Other eventsNews the company chose to file
    1 · latest 20 Nov 2025

Each line is one kind of news, with what it means in plain words. Each square is one filing; a filing can carry more than one kind, so the squares can add up to more than the filings. The date opens the latest one on EDGAR.

How it compares

every company on the site

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every filing as a table

    In the last twelve months CVS Health Corp. filed 20 documents with the SEC of the kinds listed here: 10 current reports (8-K), about 4 results of operations; 3 regulation FD disclosure; 3 officer or director change; 1 shareholder vote; 1 other events; 3 quarterly reports (10-Q), 1 employee plan annual report (11-K), 1 employee share plan registration (S-8), 1 shelf registration (S-3ASR), 1 annual report to shareholders (ARS), 1 additional proxy material (DEFA14A). The latest, filed 4 November 2026: 8-K, regulation FD disclosure. The reports, the proxy statement and the prospectus themselves, where filed, each with a link to open it, are on the documents page.

    FiledFormWhat it was aboutPeriod or event dateFiling
    4 November 20268-KRegulation FD disclosure4 November 2026EDGAR
    4 November 202610-Qquarterly report30 September 2026EDGAR
    4 November 20268-KResults of operations4 November 2026EDGAR
    17 August 20268-KOfficer or director change, Regulation FD disclosure13 August 2026EDGAR
    5 August 202610-Qquarterly report30 June 2026EDGAR
    5 August 20268-KResults of operations5 August 2026EDGAR
    23 June 202611-Kemployee plan annual report31 December 2025EDGAR
    22 May 2026S-8employee share plan registrationEDGAR
    22 May 2026S-3ASRshelf registrationEDGAR
    18 May 20268-KOfficer or director change, Shareholder vote14 May 2026EDGAR
    6 May 202610-Qquarterly report31 March 2026EDGAR
    6 May 20268-KResults of operations6 May 2026EDGAR
    3 April 2026ARSannual report to shareholders31 December 2025EDGAR
    3 April 2026DEFA14Aadditional proxy materialEDGAR
    3 April 2026DEF 14Aproxy statement14 May 2026EDGAR
    19 March 20268-KOfficer or director change18 March 2026EDGAR
    10 February 202610-Kannual report31 December 2025EDGAR
    10 February 20268-KResults of operations10 February 2026EDGAR
    9 December 20258-KRegulation FD disclosure9 December 2025EDGAR
    20 November 20258-KOther events20 November 2025EDGAR
    An 8-K is what a company files within four business days of a material event; the SEC numbers the events, and the words here are the SEC's own headings, shortened.
    Read moreForm 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.